Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α
Pedersen, Astrid, Thrane, Susan, Lykkesfeldt, Anne, Yde, ChristinaLanguage:
english
Journal:
International Journal of Oncology
DOI:
10.3892/ijo.2014.2619
Date:
August, 2014
File:
PDF, 730 KB
english, 2014